These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10964754)

  • 1. STAT5-Dependent CyclinD1 and Bcl-xL expression in Bcr-Abl-transformed cells.
    de Groot RP; Raaijmakers JA; Lammers JW; Koenderman L
    Mol Cell Biol Res Commun; 2000 May; 3(5):299-305. PubMed ID: 10964754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells.
    Hoover RR; Gerlach MJ; Koh EY; Daley GQ
    Oncogene; 2001 Sep; 20(41):5826-35. PubMed ID: 11593388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
    Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
    Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells.
    Huang M; Dorsey JF; Epling-Burnette PK; Nimmanapalli R; Landowski TH; Mora LB; Niu G; Sinibaldi D; Bai F; Kraker A; Yu H; Moscinski L; Wei S; Djeu J; Dalton WS; Bhalla K; Loughran TP; Wu J; Jove R
    Oncogene; 2002 Dec; 21(57):8804-16. PubMed ID: 12483533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line.
    Dumon S; Santos SC; Debierre-Grockiego F; Gouilleux-Gruart V; Cocault L; Boucheron C; Mollat P; Gisselbrecht S; Gouilleux F
    Oncogene; 1999 Jul; 18(29):4191-9. PubMed ID: 10435632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic profiling of acquired resistance to apoptosis in cells derived from human atherosclerotic lesions: potential role of STATs, cyclinD1, BAD, and Bcl-XL.
    Gagarin D; Yang Z; Butler J; Wimmer M; Du B; Cahan P; McCaffrey TA
    J Mol Cell Cardiol; 2005 Sep; 39(3):453-65. PubMed ID: 16005468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoreactivity of Stat5 phosphorylated on tyrosine as a cell-based measure of Bcr/Abl kinase activity.
    Jacobberger JW; Sramkoski RM; Frisa PS; Ye PP; Gottlieb MA; Hedley DW; Shankey TV; Smith BL; Paniagua M; Goolsby CL
    Cytometry A; 2003 Aug; 54(2):75-88. PubMed ID: 12879454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells.
    Huang M; Page C; Reynolds RK; Lin J
    Gynecol Oncol; 2000 Oct; 79(1):67-73. PubMed ID: 11006034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
    Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
    Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed neutrophil apoptosis in bovine subclinical mastitis.
    Boutet P; Boulanger D; Gillet L; Vanderplasschen A; Closset R; Bureau F; Lekeux P
    J Dairy Sci; 2004 Dec; 87(12):4104-14. PubMed ID: 15545372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation.
    Kieslinger M; Woldman I; Moriggl R; Hofmann J; Marine JC; Ihle JN; Beug H; Decker T
    Genes Dev; 2000 Jan; 14(2):232-44. PubMed ID: 10652277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulatory effect of STAT5 decoy oligonucleotides on trans-activation of bcl-x gene promoter in K562 cells].
    Zeng JM; Feng WL; Wang XZ; Shi M; Tu ZG; Huang ZG
    Ai Zheng; 2005 Apr; 24(4):414-8. PubMed ID: 15820062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multikinase inhibitor sorafenib induces apoptosis in highly imatinib mesylate-resistant bcr/abl+ human leukemia cells in association with signal transducer and activator of transcription 5 inhibition and myeloid cell leukemia-1 down-regulation.
    Rahmani M; Nguyen TK; Dent P; Grant S
    Mol Pharmacol; 2007 Sep; 72(3):788-95. PubMed ID: 17595328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect on bcr-abl signaling pathway and the mechanisms of apoptosis induction by meisoindigo in K562 cells].
    Liu BC; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):815-8. PubMed ID: 19176035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL.
    Amarante-Mendes GP; McGahon AJ; Nishioka WK; Afar DE; Witte ON; Green DR
    Oncogene; 1998 Mar; 16(11):1383-90. PubMed ID: 9525737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL.
    Horita M; Andreu EJ; Benito A; Arbona C; Sanz C; Benet I; Prosper F; Fernandez-Luna JL
    J Exp Med; 2000 Mar; 191(6):977-84. PubMed ID: 10727459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcr/Abl activates transcription of the Bcl-X gene through STAT5.
    Gesbert F; Griffin JD
    Blood; 2000 Sep; 96(6):2269-76. PubMed ID: 10979976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
    Carlesso N; Frank DA; Griffin JD
    J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCR/abl leads to the constitutive activation of Stat proteins, and shares an epitope with tyrosine phosphorylated Stats.
    Frank DA; Varticovski L
    Leukemia; 1996 Nov; 10(11):1724-30. PubMed ID: 8892675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT5 activation by BCR-Abl contributes to transformation of K562 leukemia cells.
    de Groot RP; Raaijmakers JA; Lammers JW; Jove R; Koenderman L
    Blood; 1999 Aug; 94(3):1108-12. PubMed ID: 10419904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.